Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P160007/S055

Simplera System

Medtronic Minimed · Decision date Sep 12, 2025

FDA DECISIONP160007/S055

What did the FDA decide?

FDA records P160007/S055 as a supplement to PMA P160007, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Sep 12, 2025.

FDA approval order statement

a change to the patch bonding process of Simplera and Simplera Sync sensors. The Simplera Sensor is a component of the Simplera system. The Simplera Sync sensor is a component of the MiniMed 670G, MiniMed 770G, and MiniMed 780G systems
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Clinical Chemistry
Decision date
Sep 12, 2025
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P160007/S055
Regulatory pathway
PMA supplement
Product code
MDS
Decision code
OK30
Decision date
Sep 12, 2025
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Sensor, glucose, invasive.

Product code
MDS
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P160007/S055 received

    Application receipt date recorded by FDA.

  2. P160007/S053 · Related supplement

    Guardian Connect system

  3. P160007/S055 · FDA decision

    30-Day Notice

  4. P160007/S054 · Related supplement

    Guardian Connect System

  5. P160007/S056 · Related supplement

    Guardian Connect System Simplera System

  6. P160007/S058 · Related supplement

    MiniMed Go app; Simplera sensor

  7. P160007/S062 · Related supplement

    Simplera and Simplera Sync

  8. P160007/S063 · Related supplement

    Simplera System; Simplera Sync

Timeline entries are records held by MedtechLedger for P160007. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P160007

Product / regulatory recordCompanyPathwayDecision dateSource
Medtronic MinimedPMA supplementAug 25, 2025FDA
Medtronic MinimedPMA supplementOct 9, 2025FDA
Medtronic MinimedPMA supplementOct 16, 2025FDA
Simplera SystemP160007/S057
Medtronic MinimedPMA supplementDec 5, 2025FDA
Simplera SystemP160007/S059
Medtronic MinimedPMA supplementDec 8, 2025FDA
Medtronic MinimedPMA supplementJan 23, 2026FDA
Medtronic MinimedPMA supplementMay 26, 2026FDA
Simplera systemP160007/S060
Medtronic MinimedPMA supplementJun 12, 2026FDA
Medtronic MinimedPMA supplementJul 21, 2026FDA

Explore the linked device profile

Other records with product code MDS

Product / regulatory recordCompanyPathwayDecision dateSource
Abbott Diabetes Care, Inc.PMA supplementSep 1, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medtronic Minimed

Headquarters
Not reported
Brand website
medtronic.com
FDA applicant address
18000 Devonshire St., Northridge, CA, 91325

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records